Relationship Between the Fecal Microbiota and Depression and Anxiety in Pediatric Patients With Orthostatic

Wakako Ishii1,2, Shihoko Komine-Aizawa3,2, Chika Takano1,2

  • 1Department of Pediatrics and Child Health, Nihon University School of Medicine, Tokyo, Japan.

Insights

Children with orthostatic intolerance (OI) have altered gut bacteria, with specific changes linked to depression. Intestinal flora may be a new target for managing pediatric OI and mental health.

Area of Science:

  • Microbiome research
  • Pediatric gastroenterology
  • Child and adolescent psychiatry

Background:

  • Orthostatic intolerance (OI) is a significant health issue in children and adolescents.
  • Psychosocial factors influence OI onset and severity.
  • The role of intestinal microbiota in pediatric mental health is not well understood.

Purpose of the Study:

  • To investigate the intestinal microbiota in children with OI.
  • To explore the relationship between intestinal microbiota and mental health in pediatric OI patients.

Main Methods:

  • Analysis of 56 fecal samples from pediatric OI patients and 9 from healthy children using terminal-restriction fragment length polymorphism.
  • Assessment of bacterial diversity via Shannon-Wiener and Simpson indices.
  • Evaluation of mental health using the Children's Depression Inventory and Children's Manifest Anxiety Scale.

Main Results:

  • A higher proportion of Clostridium subcluster XIVa and/or Enterobacteriaceae was observed in pediatric OI patients compared to controls (P = .02).
  • Bifidobacterium was less frequent in OI patients with depression than in those without depression.
  • No correlation was found between depression, anxiety, and overall bacterial diversity.

Conclusions:

  • Pediatric patients with OI exhibit distinct alterations in their intestinal bacterial flora.
  • Intestinal microbiota represents a potential novel therapeutic target for managing treatment-resistant pediatric OI and associated mental health conditions.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
276
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
203
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
262
Long-term Depression01:05

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
33.2K
Relationship Formation02:12

Relationship Formation

What do you think is the single most influential factor in determining with whom you become friends and whom you form romantic relationships? You might be surprised to learn that the answer is simple: the people with whom you have the most contact. This most important factor is proximity. You are more likely to be friends with people you have regular contact with. For example, there are decades of research that shows that you are more likely to become friends with people who live in your dorm,...
45.3K